Companies / Anacalypsis Therapeutics
Anacalypsis Therapeutics
Athens, Greece
Anacalypsis Therapeutics is developing precision gene- and pathway-based disease-modifying therapeutic strategies to disrupt the progression of neurodegenerative diseases
Anacalypsis Therapeutics, based in Athens, Greece, has 1 investor on file, among them Metavallon VC. Its latest round on record is Pre-Seed, 21 Sept 2026. Its site was last checked 6 Nov 2026: site answers.
Funding
1 round on recordRound sizes and total raised are on Fundup AI, our sister product for funding data.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Page + round | Venture capital |
More from Metavallon VC
28 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (25%), AI & Machine Learning (16%), E-commerce & Marketplaces (9%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Anacalypsis Therapeutics and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Metavallon VC adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/anacalypsistherapeutics.com/investors
# also
GET /v1/companies/anacalypsistherapeutics.com
GET /v1/companies/anacalypsistherapeutics.com/news